Terms: = Lymphoma AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
113 results:
1. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell lymphoma or Large B-Cell lymphoma?
Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ
Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893
[TBL] [Abstract] [Full Text] [Related]
2. Endoscopic Ultrasonography-Guided Fine-Needle Aspiration for Duodenal Subepithelial Lesions Showing a Hypoechoic Mass on Endoscopic Ultrasound Imaging.
Akahoshi K; Akahoshi K; Shiratsuchi Y; Tamura S; Uemura K; Sashihara R; Ohishi Y; Inoue K; Koga T; Koga H
Turk J Gastroenterol; 2023 Nov; 34(11):1156-1162. PubMed ID: 37681269
[TBL] [Abstract] [Full Text] [Related]
3.
Iaquinta G; Scalzulli E; Angeloni S; Carmosino I; Costa A; Ielo C; Passucci M; Masucci C; Martelli M; Grammatico P; Breccia M
Leuk Lymphoma; 2023 Oct; 64(10):1730-1732. PubMed ID: 37435984
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma.
Yang M; Niu X; Yang X; Sun Y; Su W; Zhang J; Wu Q; Wang Y; Zhang Q; Ji H
Exp Biol Med (Maywood); 2023 Sep; 248(17):1469-1478. PubMed ID: 36847415
[TBL] [Abstract] [Full Text] [Related]
5. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric Cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
Tao Y; You W
Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
[TBL] [Abstract] [Full Text] [Related]
6. Visible- and near-infrared hyperspectral imaging for the quantitative analysis of PD-L1+ cells in human lymphomas: Comparison with fluorescent multiplex immunohistochemistry.
Brunner A; Willenbacher E; Willenbacher W; Zelger B; Zelger P; Huck CW; Pallua JD
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121940. PubMed ID: 36208576
[TBL] [Abstract] [Full Text] [Related]
7. Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell-like diffuse large B-cell lymphoma cells.
Yi L; Hu L; Huang K; Li Q; Wang Y; Wang J; Zhai Z
Anticancer Drugs; 2023 Feb; 34(2):257-268. PubMed ID: 36206105
[TBL] [Abstract] [Full Text] [Related]
8. Druggable host gene dependencies in primary effusion lymphoma.
Kuehnle N; Gottwein E
Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
[TBL] [Abstract] [Full Text] [Related]
9. Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP; Doroshow JH; Takebe N
Lancet; 2022 Aug; 400(10351):512-521. PubMed ID: 35964611
[TBL] [Abstract] [Full Text] [Related]
10. Identification and therapeutic evaluation of ALK rearrangements in non-small-cell lung cancer.
Zhao R; Guo L; Zhang B; Zhao J; Xiang C; Chen S; Shao J; Zhu L; Ye M; Han Y
J Pathol Clin Res; 2022 Nov; 8(6):538-549. PubMed ID: 35848751
[TBL] [Abstract] [Full Text] [Related]
11. [Correlation between Serum miR-34a Level and Thrombocytopenia after Chemotherapy in Patients with Diffuse Large B-Cell lymphoma].
Zhang HL; Uticul A; Xu XW; Shi YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):784-789. PubMed ID: 35680806
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological and molecular genetic features of cyclin D1-negative mantle cell lymphoma].
Wang GN; Zhang L; Li CF; Zhao WG; Zhang DD; Zhang YP; Li WC
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):296-300. PubMed ID: 35359039
[No Abstract] [Full Text] [Related]
13. Serum lipid trajectories in the years before a lymphoma diagnosis.
Fortuny J; Plana E; Kaye JA
Leuk Lymphoma; 2022 Feb; 63(2):291-303. PubMed ID: 34963420
[TBL] [Abstract] [Full Text] [Related]
14. Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed between 2001 and 2014.
Yin MM; Wu RC; Gao J; Hu SY; Liu XM; Zhu XF; Shen SH; Tang JY; Chen J; Hu Q
Curr Med Sci; 2022 Feb; 42(1):201-209. PubMed ID: 34874488
[TBL] [Abstract] [Full Text] [Related]
15. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Ishio T; Kumar S; Shimono J; Daenthanasanmak A; Dubois S; Lin Y; Bryant B; Petrus MN; Bachy E; Huang DW; Yang Y; Green PL; Hasegawa H; Maeda M; Goto H; Endo T; Yokota T; Hatanaka KC; Hatanaka Y; Tanaka S; Matsuno Y; Yang Y; Hashino S; Teshima T; Waldmann TA; Staudt LM; Nakagawa M
Blood; 2022 Mar; 139(10):1541-1556. PubMed ID: 34818414
[TBL] [Abstract] [Full Text] [Related]
16. Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study.
Jensen KS; Klug Albertsen B; Schrøder H; Zalounina Falborg A; Schmiegelow K; Rosthøj S; Callesen MT; Vedsted P
BMJ Open; 2021 Nov; 11(11):e049847. PubMed ID: 34810184
[TBL] [Abstract] [Full Text] [Related]
17. [Development of acute kidney injury prognostic model for critically ill patients based on MIMIC-III database].
Li M; Yang H; Yang W; Wei B; Zhang Y; Xie R; Chu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):949-954. PubMed ID: 34590562
[TBL] [Abstract] [Full Text] [Related]
18. Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Orellana-Noia VM; Reed DR; McCook AA; Sen JM; Barlow CM; Malecek MK; Watkins M; Kahl BS; Spinner MA; Advani R; Voorhees TJ; Snow A; Grover NS; Ayers A; Romancik J; Liu Y; Huntington SF; Chavez JC; Saeed H; Lazaryan A; Raghunathan V; Spurgeon SE; Ollila TA; Del Prete C; Olszewski A; Ayers EC; Landsburg DJ; Echalier B; Lee J; Kamdar M; Caimi PF; Fu T; Liu J; David KA; Alharthy H; Law J; Karmali R; Shah H; Stephens DM; Major A; Rojek AE; Smith SM; Yellala A; Kallam A; Nakhoda S; Khan N; Sohail MA; Hill BT; Barrett-Campbell O; Lansigan F; Switchenko J; Cohen J; Portell CA
Blood; 2022 Jan; 139(3):413-423. PubMed ID: 34570876
[TBL] [Abstract] [Full Text] [Related]
19. Integrative analysis of hub genes and key pathway in two subtypes of diffuse large B-cell lymphoma by bioinformatics and basic experiments.
Li Q; Meng Y; Hu L; Charwudzi A; Zhu W; Zhai Z
J Clin Lab Anal; 2021 Nov; 35(11):e23978. PubMed ID: 34545634
[TBL] [Abstract] [Full Text] [Related]
20. Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.
Eertink JJ; Arens AIJ; Huijbregts JE; Celik F; de Keizer B; Stroobants S; de Jong D; Wiegers SE; Zwezerijnen GJC; Burggraaff CN; Boellaard R; de Vet HCW; Hoekstra OS; Lugtenburg PJ; Chamuleau MED; Zijlstra JM;
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):943-952. PubMed ID: 34476551
[TBL] [Abstract] [Full Text] [Related]
[Next]
